BNP PARIBAS FINANCIAL MARKETS - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 152 filers reported holding THERAVANCE INC in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$87,630,000
-33.6%
8,314
-54.8%
0.00%
Q3 2015$131,954,000
+3.1%
18,378
+159.4%
0.00%
Q2 2015$128,008,000
+317.4%
7,084
+263.1%
0.00%
Q1 2015$30,670,000
-63.7%
1,951
-60.5%
0.00%
Q3 2014$84,425,000
-100.0%
4,940
-100.0%
0.00%
-100.0%
Q4 2013$2,326,080,000,000
+186.1%
16,000,000
+220.0%
0.85%
+43.5%
Q3 2013$813,100,000,000
+5.5%
5,000,0000.0%0.59%
+8.4%
Q2 2013$770,600,000,0005,000,0000.54%
Other shareholders
THERAVANCE INC shareholders Q2 2013
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders